Valuation | Industry Range | |
---|---|---|
Price / Earnings | N/A | |
Book Value | -0.05 |   |
Earnings Per Share | -$0.17 |   |
Price To Sales Ratio | 3.14 |   |
Price To Book Ratio | 2.1K |   |
Price To Tangible Book Ratio | N/A | |
Price/Cash Flow Ratio | N/A | |
Price/Free Cash Flow Ratio | N/A |
Profile | Industry Range | |
---|---|---|
Market Capitalization | 409.2M |   |
Float (MRQ) | 65.82% |   |
Shares Outstanding (MRQ) | 111.6M |   |
Short Interest as a % of Float (MRQ) | 3.31% |   |
Shares Held By Institutions (MRQ) | 26.5M |   |
Margins | Industry Range | |
---|---|---|
Sales | $257.5M |   |
Gross Margin | 82.79% |   |
Net Profit Margin | -4.81% |   |
EBIT Margin | -2.89% |   |
EBITDA Margin | -0.61% |   |
Operating Margins | -2.89% |   |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
Financial Strength | Industry Range | |
---|---|---|
Current Ratio (MRQ) | 3.47 |   |
Quick Ratio (MRQ) | 3.20 |   |
Total Debt/Equity Ratio (MRQ) | 56.71 |   |
Debt/Common Equity Ratio (MRQ) | N/A |
Effectiveness | Industry Range | |
---|---|---|
Return on Equity | -14.18% |   |
Return on Assets | -8.69% |   |
Asset Turnover | 1.81 |   |
Receivables Turnover | 6.60 |   |
Inventory Turnover | 3.86 |   |
Earnings and Dividends | Industry Range | |
---|---|---|
EPS Growth Annual | -79.27% |   |
Dividend Yield 5 Year Average | 0.00% |   |
Current Dividend Yield | 0.00% |   |
Current Payout Ratio | N/A |
*MDXG does not pay a dividend. The average dividend yield for companies in the Biotechnology industry is 1.53%